$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

$areb Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224032142 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue		$3.255M	$3.671M
YoY Change		-11.31%	983.7%
Cost Of Revenue		$3.225M	$2.983M
YoY Change		8.12%	1137.23%
Gross Profit		$30.66K	$687.9K
YoY Change		-95.54%	604.6%
Gross Profit Margin		0.94%	18.74%
Selling, General & Admin		$3.310M	$2.041M
YoY Change		62.21%	43.84%
% of Gross Profit		10799.12%	296.68%
Research & Development		$337.8K
YoY Change
% of Gross Profit		1101.85%
Depreciation & Amortization		$30.68K	$25.28K
YoY Change		21.36%	5395.65%
% of Gross Profit		100.08%	3.68%
Operating Expenses		$3.979M	$2.239M
YoY Change		77.72%	33.12%
Operating Profit		-$3.948M	-$1.551M
YoY Change		154.57%	-2.1%
Interest Expense		-$1.055M	$148.4K
YoY Change		-810.79%	724.6%
% of Operating Profit
Other Income/Expense, Net		-$1.305M	$1.108M
YoY Change		-217.82%
Pretax Income		-$5.253M	-$590.2K
YoY Change		790.03%	-63.16%
Income Tax
% Of Pretax Income
Net Earnings		-$5.253M	-$590.2K
YoY Change		790.03%	-63.16%
Net Earnings / Revenue		-161.36%	-16.08%
Basic Earnings Per Share		-$0.89	-$0.87
Diluted Earnings Per Share		-$0.89	-$0.87
COMMON SHARES
Basic Shares Outstanding	8.407M shares	5.948M shares	16.93M shares
Diluted Shares Outstanding		5.880M shares	679.0K shares

Balance Sheet

Concept	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$452.8K	$2.733M
YoY Change	-83.43%	8.9%
Cash & Equivalents	$452.8K	$2.733M
Short-Term Investments
Other Short-Term Assets	$191.6K	$160.3K
YoY Change	19.53%	-69.73%
Inventory	$6.357M	$8.874M
Prepaid Expenses	$191.6K	$160.3K
Receivables	$2.144M	$1.982M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$9.460M	$13.75M
YoY Change	-31.2%	215.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$310.8K	$402.2K
YoY Change	-22.72%	2947.57%
Goodwill	$2.000M	$4.200M
YoY Change	-52.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.392M	$5.716M
YoY Change	-40.67%	120245.07%
Total Long-Term Assets	$3.703M	$6.119M
YoY Change	-39.49%	33994.21%
TOTAL ASSETS
Total Short-Term Assets	$9.460M	$13.75M
Total Long-Term Assets	$3.703M	$6.119M
Total Assets	$13.16M	$19.87M
YoY Change	-33.75%	353.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.453M	$2.289M
YoY Change	7.15%	331.38%
Accrued Expenses	$1.204M	$1.069M
YoY Change	12.62%	1474.57%
Deferred Revenue
YoY Change
Short-Term Debt	$3.732M	$1.482M
YoY Change	151.73%	145.02%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.12M	$6.347M
YoY Change	59.48%	425.39%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$521.6K	$521.7K
YoY Change	-0.02%
Total Long-Term Liabilities	$521.6K	$521.7K
YoY Change	-0.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.12M	$6.347M
Total Long-Term Liabilities	$521.6K	$521.7K
Total Liabilities	$10.64M	$6.868M
YoY Change	54.96%	468.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.17M	-$34.93M
YoY Change	52.21%	11.96%
Common Stock	$5.880K	$749.00
YoY Change	685.05%	-84.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.520M	$13.00M
YoY Change
Total Liabilities & Shareholders Equity	$13.16M	$19.87M
YoY Change	-33.75%	353.44%

Cashflow Statement

Concept	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$5.253M	-$590.2K
YoY Change	790.03%	-63.16%
Depreciation, Depletion And Amortization	$30.68K	$25.28K
YoY Change	21.36%	5395.65%
Cash From Operating Activities	-$1.789M	-$784.3K
YoY Change	128.14%	-19.93%
INVESTING ACTIVITIES
Capital Expenditures	$5.940K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$1.400K
YoY Change		-110.26%
Cash From Investing Activities	-$6.350K	$1.400K
YoY Change	-553.57%	-110.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.574M	3.050M
YoY Change	-48.41%	-55760.95%
NET CHANGE
Cash From Operating Activities	-1.789M	-784.3K
Cash From Investing Activities	-6.350K	1.400K
Cash From Financing Activities	1.574M	3.050M
Net Change In Cash	-222.1K	2.267M
YoY Change	-109.8%	-327.02%
FREE CASH FLOW
Cash From Operating Activities	-$1.789M	-$784.3K
Capital Expenditures	$5.940K
Free Cash Flow	-$1.795M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2816541	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	190933	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5787993	usd
CY2023Q4	AREB	Inventory Deposits InventoryDeposits	315083	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10258246	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	360495	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	83400	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1946567	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4029967	usd
CY2023Q4	us-gaap	Assets Assets	14648708	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1978768	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	271076	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2014-12-15
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001648087
CY2023Q2	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense		usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2024Q2	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
CY2023Q2	AREB	Gainloss On Settlement Of Debt Instrument GainlossOnSettlementOfDebtInstrument		usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
	AREB	Gainloss On Settlement Of Debt Instrument GainlossOnSettlementOfDebtInstrument		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	AREB	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2023Q2	AREB	Post Quarter Effectuation Of Round Lot Share Issuance PostQuarterEffectuationOfRoundLotShareIssuance		usd
	AREB	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	AREB	Post Quarter Effectuation Of Round Lot Share Issuance PostQuarterEffectuationOfRoundLotShareIssuance		usd
	AREB	Loss On Settlement Of Debt LossOnSettlementOfDebt		usd
	AREB	Settlement Of Revenue Interest Purchase Note Through Issuance Of Preferred Stock SettlementOfRevenueInterestPurchaseNoteThroughIssuanceOfPreferredStock		usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	AREB	Note Payable Principal And Interest Associated With Revenue Interest Purchase Conversion Series D Preferred Stock NotePayablePrincipalAndInterestAssociatedWithRevenueInterestPurchaseConversionSeriesDPreferredStock		usd
	AREB	Notes Payable Related Party Principal Increase From Assessed Interest Obligations NotesPayableRelatedPartyPrincipalIncreaseFromAssessedInterestObligations		usd
	AREB	Notes Payable Principal Increase From Assessed Interest Obligations NotesPayablePrincipalIncreaseFromAssessedInterestObligations		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2024Q2	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset
CY2024Q2	AREB	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41267
	dei	Entity Registrant Name EntityRegistrantName	AMERICAN REBEL HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3892903
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5115 Maryland Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 303
	dei	Entity Address City Or Town EntityAddressCityOrTown	Brentwood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37027
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	267-3235
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8406729	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	452785	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1147696	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	2143808	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	191605	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	6357118	usd
CY2024Q2	AREB	Inventory Deposits InventoryDeposits	315084	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	9460400	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	310776	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	78954	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1312831	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2000000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3391785	usd
CY2024Q2	us-gaap	Assets Assets	13162961	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2452588	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	413160	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	3731790	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1992129	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	791222	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1039081	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10121682	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6745400	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	521609	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	907486	usd
CY2024Q2	us-gaap	Liabilities Liabilities	10643291	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7652886	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	333000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	333000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	200000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	200000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5879920	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5879920	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5879920	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5879920	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	5880	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	5880	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55681333	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52203336	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53167876	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45213594	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2519670	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6995822	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13162961	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14648708	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3255393	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3670571	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	3224738	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2982688	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	30655	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	687883	usd
CY2024Q2	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	445166	usd
CY2023Q2	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	828520	usd
CY2024Q2	AREB	Officerl Compensation Expense OfficerlCompensationExpense	212500	usd
CY2023Q2	AREB	Officerl Compensation Expense OfficerlCompensationExpense	102985	usd
CY2024Q2	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1344125	usd
CY2024Q2	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	80515	usd
CY2023Q2	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	275474	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	337771	usd
CY2024Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	299655	usd
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	172617	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1228163	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	833851	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30681	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25275	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	3978576	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2238722	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3947921	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1550839	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1055282	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	148437	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	199	usd
CY2023Q2	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect	1107672	usd
CY2024Q2	AREB	Gainloss On Settlement Of Debt Instrument GainlossOnSettlementOfDebtInstrument	-250000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1305083	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	960635	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5253004	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-590204	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-5253004	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-590204	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.89
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.89
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5879920	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5879920	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	679000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	679000	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7299230	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8072670	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6427252	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5774014	usd
	us-gaap	Gross Profit GrossProfit	871978	usd
	us-gaap	Gross Profit GrossProfit	2298656	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	997079	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1684846	usd
	AREB	Officerl Compensation Expense OfficerlCompensationExpense	425000	usd
	AREB	Officerl Compensation Expense OfficerlCompensationExpense	191258	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	2478125	usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	232181	usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	502134	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	436400	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16495	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	564710	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	425342	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1908677	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1195000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54996	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54365	usd
	us-gaap	Operating Expenses OperatingExpenses	7097168	usd
	us-gaap	Operating Expenses OperatingExpenses	4069440	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6225190	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1770784	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1479141	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	155547	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	711	usd
	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect	1107672	usd
	AREB	Gainloss On Settlement Of Debt Instrument GainlossOnSettlementOfDebtInstrument	-250000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-662	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1729092	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	953525	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7954282	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-817259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7954282	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5879920	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5879920	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	678000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	678000	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11126064	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	312452	usd
CY2023Q2	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	2681400	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-529324	usd
CY2023Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2093591	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-590204	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13000388	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5428544	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1344125	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	500000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	250005	usd
CY2024Q2	AREB	Premium Payment PremiumPayment	250000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1000005	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-5253004	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2519670	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	312452	usd
	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	2681400	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-529324	usd
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2093591	shares
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13000388	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6995822	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6995822	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2478125	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	500000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	250005	usd
	AREB	Premium Payment PremiumPayment	250000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1000005	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7954282	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7954282	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2519670	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2519670	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7954282	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54996	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54365	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-662	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
	AREB	Loss On Settlement Of Debt LossOnSettlementOfDebt	250000	usd
	AREB	Settlement Of Revenue Interest Purchase Note Through Issuance Of Preferred Stock SettlementOfRevenueInterestPurchaseNoteThroughIssuanceOfPreferredStock	750005	usd
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	2478125	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-672733	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	368993	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3774	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-46756	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	569126	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1153758	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	473820	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-234630	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	142084	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3697209	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2474919	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	5939	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1402	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5939	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1402	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	312452	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2152076	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1700000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	535200	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	-340317	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	215461	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	146000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	400000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2091503	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1000000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	233927	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	120195	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3008237	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4850016	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-694911	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2376499	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1147696	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	356754	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	452785	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2733253	usd
	us-gaap	Interest Paid Net InterestPaidNet	281666	usd
	us-gaap	Interest Paid Net InterestPaidNet	156252	usd
	AREB	Note Payable Principal And Interest Associated With Revenue Interest Purchase Conversion Series D Preferred Stock NotePayablePrincipalAndInterestAssociatedWithRevenueInterestPurchaseConversionSeriesDPreferredStock	1000005	usd
	AREB	Notes Payable Related Party Principal Increase From Assessed Interest Obligations NotesPayableRelatedPartyPrincipalIncreaseFromAssessedInterestObligations	80000	usd
	AREB	Notes Payable Principal Increase From Assessed Interest Obligations NotesPayablePrincipalIncreaseFromAssessedInterestObligations	1189795	usd
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_84D_eus-gaap--FiscalPeriod_zN9ytOcyVCg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zhMAh55LhT8l">Year-end</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	AREB	Revenue Recognition Percentage RevenueRecognitionPercentage	1	pure
CY2023Q2	AREB	Revenue Recognition Percentage RevenueRecognitionPercentage	1	pure
	AREB	Revenue Recognition Percentage RevenueRecognitionPercentage	1	pure
	AREB	Revenue Recognition Percentage RevenueRecognitionPercentage	1	pure
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	2143808	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2816541	usd
CY2024Q2	us-gaap	Marketing Expense MarketingExpense	299655	usd
CY2023Q2	us-gaap	Marketing Expense MarketingExpense	172617	usd
	us-gaap	Marketing Expense MarketingExpense	564710	usd
	us-gaap	Marketing Expense MarketingExpense	425342	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.89
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z2Sapcwss888" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zLKVBeDRboyd">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	AREB	Warranty Liability WarrantyLiability	85000	usd
CY2023Q4	AREB	Warranty Liability WarrantyLiability	82238	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7954282	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53167876	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45213594	usd
CY2024Q2	AREB	Working Capital WorkingCapital	129940	usd
CY2023Q4	AREB	Working Capital WorkingCapital	4551927	usd
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	20000000.0	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	4348031	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4017381	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2009087	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1770612	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	6357118	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5787993	usd
CY2024Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	60000	usd
CY2024Q2	AREB	Inventory Finished Goods Written Off InventoryFinishedGoodsWrittenOff	180000	usd
	AREB	Inventory Finished Goods Written Off InventoryFinishedGoodsWrittenOff	180000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	773437	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	789038	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	462661	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	428543	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	310776	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	360495	usd
CY2024Q2	us-gaap	Depreciation Depreciation	30681	usd
CY2023Q2	us-gaap	Depreciation Depreciation	25275	usd
	us-gaap	Depreciation Depreciation	54996	usd
	us-gaap	Depreciation Depreciation	54365	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1992129	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1992129	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1456929	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	3731790	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	3731790	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	3731790	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1954214	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2000000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	55856751	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	45213594	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11729920	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9494850	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11729920	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9494850	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11729920	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9494850	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11729920	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9494850	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	As a result, management determined it was more likely than not deferred tax assets will not be realized as of June 30, 2024, and December 31, 2023, and recognized 100% valuation allowance for each period
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.000	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.210	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-25
CY2024Q2	us-gaap	Share Price SharePrice	1
	AREB	Stock Issued During Period Shares Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodSharesWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	2988687	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2902.38	usd
CY2023Q3	AREB	Gain On Settlement Of Debt GainOnSettlementOfDebt	228000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	24129	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2993850.63	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	71499	shares
CY2023Q2	us-gaap	Share Price SharePrice	4.37
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	615000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.37
	AREB	Stock Issued During Period Shares Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodSharesWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	2988687	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1096455	shares
CY2022Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	30.50
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	615000	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	4.37
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2023	AREB	Share Based Payment Award Non Options Granted Debt Conversion ShareBasedPaymentAwardNonOptionsGrantedDebtConversion	686499	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Granted Debt Conversion Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantedDebtConversionExercisePrice	4.24
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Granted Debt Conversion Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualGrantedDebtConversionTerm2	P5Y
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Prefunded Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPrefundedWarrant	1365251	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted Prefunded Warrant Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedPrefundedWarrantWeightedAverageExercisePrice	1.10
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P4Y
CY2023	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Pipe Transaction ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodPipeTransaction	5977374	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted Pipe Transaction Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedPipeTransactionWeightedAverageExercisePrice	1.10
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	3603687	shares
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	0.88
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Granted Weighted Average Exercised Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageExercisedRemainingContractualTerm2	P5Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	6136892	shares
CY2023Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.15
CY2023	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	6136892	shares
CY2024Q2	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.15
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2023	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted Pipe Transaction Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedPipeTransactionWeightedAverageExercisePrice	1.10
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	185000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	225000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	370000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	450000	usd
CY2023Q4	AREB	Operating Lease Right Of Use Asset And Liability OperatingLeaseRightOfUseAssetAndLiability	1000000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1312831	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1946567	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	791222	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1039081	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	521609	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	907486	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	328118	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	243501	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	638836	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	312295	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	267302	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	256782	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	64754	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1539969	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	227138	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1312831	usd
CY2024Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1992129	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	1900000	usd

Files In Submission

Name	View Source	Status
0001493152-24-032142-index-headers.html	Edgar Link	pending
0001493152-24-032142-index.html	Edgar Link	pending
0001493152-24-032142.txt	Edgar Link	pending
0001493152-24-032142-xbrl.zip	Edgar Link	pending
areb-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex99-5.htm	Edgar Link	pending
ex99-5_001.jpg	Edgar Link	pending
ex99-9.htm	Edgar Link	pending
ex99-9_001.jpg	Edgar Link	pending
ex99-9_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
areb-20240630_def.xml	Edgar Link	unprocessable
areb-20240630_pre.xml	Edgar Link	unprocessable
areb-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
areb-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

2024 Q3 Form 10-Q Financial Statement

#000149315224032142 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB AMERICAN REBEL HOLDINGS INC Stock $areb

2024 Q3 Form 10-Q Financial Statement

#000149315224032142 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb